Profile data is unavailable for this security.
About the company
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
- Revenue in JPY (TTM)192.93bn
- Net income in JPY-31.03bn
- Incorporated2021
- Employees2.97k
- LocationSawai Group Holdings Co Ltd5-2-30, Miyahara, Yodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661055818
- Websitehttps://www.sawaigroup.holdings
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd | 20.14bn | 8.04bn | 94.88bn | 994.00 | 11.80 | 3.81 | 10.07 | 4.71 | 193.21 | 193.21 | 483.67 | 597.85 | 0.4299 | 1.62 | 6.73 | 20,257,290.00 | 17.21 | 5.06 | 25.22 | 7.65 | 53.50 | 45.48 | 40.03 | 14.97 | 0.9142 | -- | 0.4231 | 24.13 | 17.46 | 0.5778 | 94.65 | -- | 9.71 | -- |
| TOWA PHARMACEUTICAL CO., LTD | 173.86bn | 9.36bn | 104.27bn | 4.08k | 10.85 | 0.7181 | 4.46 | 0.5997 | 186.62 | 186.62 | 3,473.48 | 2,818.59 | 0.5752 | 1.45 | 3.68 | 42,633,890.00 | 3.10 | 5.90 | 4.33 | 7.84 | 39.10 | 44.12 | 5.39 | 10.22 | 0.8056 | -- | 0.518 | 16.48 | 6.92 | 14.28 | 14.01 | 23.34 | -8.50 | 12.47 |
| KYORIN Holdings, Inc. | 105.53bn | 5.05bn | 110.35bn | 2.22k | 19.37 | 0.7847 | 12.48 | 1.05 | 88.18 | 88.18 | 1,841.56 | 2,176.73 | 0.621 | 1.30 | 3.04 | 47,491,000.00 | 2.97 | 3.33 | 3.66 | 4.03 | 46.13 | 51.06 | 4.79 | 5.46 | 1.87 | -- | 0.1443 | 70.59 | 2.56 | -1.77 | -35.86 | -11.65 | 0.338 | -2.16 |
| Zeria Pharmaceutical Co Ltd | 64.64bn | 5.84bn | 114.47bn | 1.74k | 16.42 | 1.54 | 10.03 | 1.77 | 131.27 | 131.27 | 1,450.17 | 1,395.01 | 0.5009 | 1.46 | 3.79 | 37,213,090.00 | 4.54 | 3.10 | 7.27 | 4.98 | 71.69 | 71.28 | 9.07 | 5.92 | 0.7455 | 6.65 | 0.4665 | 45.87 | 12.84 | -1.70 | 26.03 | 2.25 | -17.52 | 1.81 |
| Kissei Pharmaceutical Co Ltd | 65.86bn | 10.58bn | 132.12bn | 1.83k | 11.11 | 0.5877 | 9.02 | 2.01 | 229.45 | 229.45 | 1,428.10 | 4,338.62 | 0.2718 | 1.75 | 3.00 | 36,026,800.00 | 4.41 | 3.16 | 4.79 | 3.42 | 48.53 | 55.98 | 16.23 | 10.45 | 4.82 | -- | 0.0079 | 34.12 | -5.31 | -1.83 | 144.48 | 10.83 | -5.39 | 4.01 |
| Mochida Pharmaceutical Co Ltd | 109.37bn | 9.58bn | 137.35bn | 1.54k | 13.53 | 0.987 | 11.23 | 1.26 | 252.77 | 252.77 | 2,899.75 | 3,464.88 | 0.678 | 2.24 | 3.58 | 70,835,500.00 | 5.94 | 5.22 | 7.12 | 6.40 | 53.99 | 51.57 | 8.75 | 7.76 | 3.62 | -- | 0.00 | 40.56 | 6.98 | 2.51 | 23.08 | 4.39 | 21.99 | 3.04 |
| KAKEN PHARMACEUTICAL CO., LTD. | 75.27bn | 8.79bn | 173.42bn | 1.16k | 16.19 | 1.01 | 15.36 | 2.30 | 233.13 | 233.13 | 1,994.15 | 3,730.82 | 0.4522 | 2.06 | 3.65 | 64,660,650.00 | 5.28 | 10.15 | 6.03 | 12.06 | 54.43 | 56.09 | 11.68 | 18.28 | 5.04 | -- | 0.0267 | 37.00 | 1.41 | -5.61 | -28.77 | -15.39 | 6.71 | 0.00 |
| Sawai Group Holdings Co Ltd | 192.93bn | -31.03bn | 173.85bn | 2.97k | -- | 0.8596 | -- | 0.9011 | -709.06 | -709.06 | 4,400.23 | 4,618.62 | 0.4943 | 1.48 | 2.88 | 65,002,360.00 | -11.39 | 1.25 | -15.97 | 1.70 | 31.76 | 38.97 | -23.05 | 2.46 | 1.24 | -155.68 | 0.2585 | 76.82 | 3.52 | 7.92 | -329.08 | -- | 4.38 | 0.00 |
| Sosei Group Corporation | 22.76bn | -383.00m | 199.81bn | 198.00 | -- | 3.59 | 213.93 | 8.78 | -4.70 | -4.70 | 278.03 | 679.92 | 0.2473 | -- | 19.92 | 114,964,600.00 | -0.416 | -- | -0.4321 | -- | 95.45 | -- | -1.68 | -- | -- | 2.57 | 0.3475 | -- | 100.32 | -- | -31.24 | -- | -- | -- |
| TAKARA BIO INC. | 68.74bn | 18.38bn | 208.32bn | 1.67k | 11.34 | 1.95 | 9.13 | 3.03 | 152.62 | 152.62 | 570.82 | 886.08 | 0.6115 | 1.21 | 4.59 | 41,257,500.00 | 16.39 | 9.94 | 18.79 | 11.16 | 69.46 | 65.37 | 26.81 | 18.17 | 4.31 | 37.63 | 0.00 | 21.03 | 46.90 | 18.17 | 107.91 | 71.14 | 52.57 | 52.51 |
| Tsumura & Co | 136.24bn | 20.76bn | 211.62bn | 3.92k | 10.16 | 0.8188 | 6.74 | 1.55 | 271.40 | 271.40 | 1,781.06 | 3,367.09 | 0.3688 | 0.7203 | 2.47 | 34,745,470.00 | 5.83 | 5.19 | 7.06 | 6.28 | 50.34 | 55.78 | 15.80 | 12.78 | 3.66 | -- | 0.2226 | 31.45 | 11.28 | 2.42 | 22.85 | 8.57 | 4.99 | 0.00 |
| JCR Pharmaceuticals Co Ltd | 38.28bn | 6.24bn | 211.65bn | 816.00 | 32.52 | 4.02 | 25.71 | 5.53 | 50.19 | 50.19 | 308.22 | 405.71 | 0.435 | 0.7008 | 2.49 | 46,911,760.00 | 7.11 | 11.47 | 11.70 | 16.27 | 71.76 | 73.58 | 16.34 | 20.62 | 1.17 | -- | 0.2624 | 22.46 | 69.79 | 23.08 | 110.49 | 50.75 | 48.86 | 29.46 |
Data as of Jan 27 2023. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY
26.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 09 Aug 2022 | 4.04m | 9.23% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Nov 2022 | 1.47m | 3.36% |
| Nomura Asset Management Co., Ltd.as of 30 Dec 2022 | 1.38m | 3.15% |
| The Vanguard Group, Inc.as of 05 Jan 2023 | 1.10m | 2.52% |
| Nikko Asset Management Co., Ltd.as of 30 Nov 2022 | 725.00k | 1.66% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2022 | 623.00k | 1.42% |
| Dimensional Fund Advisors LPas of 05 Jan 2023 | 613.12k | 1.40% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 612.94k | 1.40% |
| Baillie Gifford & Co.as of 19 Jan 2023 | 483.80k | 1.11% |
| BlackRock Fund Advisorsas of 05 Jan 2023 | 422.80k | 0.97% |
More ▼
Data from 31 Dec 2021 - 31 Dec 2022Source: FactSet Research Systems Inc.
